Dr. Robert C. Sizemore, professor of biology at Alcorn State University, has recently been named as an editor for the Journal of Cell and Developmental Biology, an open-access and peer-reviewed journal. The journal publishes original research, review papers in the fields of evolutionary biology, cell signaling networks, human developmental anatomy, stem cell biology, cell differentiation, evolutionary developmental biology, human embryogenesis, population genetic mechanisms, cell differentiation, somatic cell genetics, etc.
“It’s an honor to be selected to serve as an editor for this outstanding publication,” stated Dr. Sizemore. “The journal encompasses several areas of biology including many that are on the cutting edge. So, it will be very exciting and challenging.”
Dr. Sizemore joined Alcorn State University in 1996 as an associate professor and since then he has been actively conducting research and teaching several courses including honors biology, evolution, medical microbiology, principles of immunology and advanced immunology. Dr. Sizemore has been promoted to full professor and granted tenure.
“My research basically involves the interactions between the immune system and the neuroendocrine system, i.e. how the brain and the immune system work together,” said Dr. Sizemore, who received over one million dollars (during his 15 years at Alcorn) in grant support from the National Institute of Health to conduct research on how small peptides derived from enkephalin modulate the immune system.
“Data from our studies suggests in part why low levels of stress can enhance the immune response while high levels can lead to suppression,” added Dr. Sizemore. “This resulted in three publications (example: “In vitro modulation of cytokine expression by enkephalin-derived peptides, NeuroImmunoModuation 12:339, 2005) and several presentations at national and international meetings.”
Dr. Sizemore served on a review panel at the National Institute of Health in Bethesda, Maryland, from 1999-2002. He currently serves as a member of the Biotechnology Group at Alcorn State University and serves on the advisory board for the Penn State-ASU Bridge to the Doctorate Program.
Prior to coming to Alcorn, Dr. Sizemore served as the director of immunology for a biotechnology company IMREG Inc. His team developed an immunotherapeutic for the treatment of AIDS that was taken through Phase I, II and III clinical trials. During this period he received two patents, published several papers and presented work at the International AIDS Conference in Stockholm, Sweden, and other meetings.
“Our group was one of the first to treat patients with a biologic, a procedure that is now more commonly accepted,” explained Dr. Sizemore. “Although the FDA found promise in what we were doing, they asked for more clinical trials, which at that time was not feasible.” He then took a full-time position at Tulane University School of Medicine where he taught immunology. Dr. Sizemore was part of a team that received the “Class of the Year Award” in microbiology. He co-authored “HIV retrotransposon activity and the immunopathogenesis of AIDS” published in Trends in Microbiology, 3:115. 1995. The research findings suggested that HIV causes immune dysfunction via genomic effects due to the presence of various cofactors.
Dr. Sizemore holds bachelor’s and master’s degrees from the University of Kentucky, Lexington, and a Ph.D. in microbiology and immunology from the University of Louisville School of Medicine, Louisville, Kentucky. He was also awarded the University of Louisville Graduate Dean’s Citation for the Year in 1983.
Dr. Sizemore resides in Natchez, Mississippi, with wife Kathy and son Carlen.